GlassScriptPhysician profile
Dennis H Mitchell
NPI 1629005715
$2,088.79
in general payments reported to CMS, 2019-2025
27 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $520 · 2022: $758 · 2023: $362 · 2024: $307 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.84 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $263.39 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $259.19 | 2021-2025 | Xtandi, Padcev |
| Janssen Biotech, INC. | $210.42 | 2022-2024 | Erleada, Akeega, Balversa |
| Urovant Sciences INC | $149.62 | 2022 | |
| 180 Medical, INC. | $127.68 | 2021-2025 | |
| Corcept Therapeutics | $97.13 | 2022 | |
| Myovant Sciences INC. | $96.67 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $95.20 | 2022 | |
| Amgen INC. | $91.42 | 2021 | |
| Pfizer INC. | $88.69 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $75.81 | 2021-2023 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $71.92 | 2022 | |
| Abbvie INC. | $66.16 | 2022-2023 | |
| Medtronic, INC. | $47.31 | 2021 | |
| Coloplast Corp | $47.15 | 2021-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $42.91 | 2021-2022 | |
| Axonics, INC. | $32.95 | 2021-2024 | Bulkamid, Axonics |
| Laborie Medical Technologies Corp. | $30.30 | 2021 | |
| Abc Home Medical Supply, INC. | $30.30 | 2024 | |
| Boston Scientific Corporation | $29.06 | 2021 | |
| Tolmar, INC. | $25.75 | 2023 | |
| Profound Medical Corp. | $23.35 | 2022 | |
| Endo USA, INC. | $22.67 | 2024 | Xiaflex |
| Dentsply Ih Ab | $17.18 | 2023 | Lofric |
| Urogen Pharma, INC. | $16.13 | 2022 | |
| Allergan, INC. | $15.99 | 2021 | |
| Myriad Genetic Laboratories, INC. | $14.44 | 2025 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.